Diffuse pulmonary hemorrhage after streptokinase administration for acute myocardial infarction

Pharmacotherapy

Volumn 17, Issue 2, 1997, Pages 390-394

  Swanson, George A ^a   Kaeley, Gurjit ^a   Geraci, Stephen A ^a,b  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; ATROPINE; DIPHENHYDRAMINE; DOPAMINE; GLYCERYL TRINITRATE; HEPARIN; MORPHINE; PENTOBARBITAL; STREPTOKINASE;

ACUTE HEART INFARCTION; ADULT; ARTICLE; BLOOD GAS ANALYSIS; CASE REPORT; FIBRINOLYTIC THERAPY; HUMAN; IMMUNE RESPONSE; LUNG HEMORRHAGE; LUNG INFECTION; MALE; SKIN INFECTION;

FIBRINOLYTIC AGENTS; HEMOPTYSIS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; STREPTOKINASE;

EID: 0030894723     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Shah PK, Zagher D, Ganz W. Streptokinase in acute myocardial infarction. In: Francis GS, Alpert JS, eds. Coronary care. Boston: Little, Brown, 1995:409-33.
2. Levine MN, Goldhaber SZ, Califf RM, Gore JM, Hirsh J. Hemorrhagic complications of thrombolytic therapy in the treatment of acute myocardial infarction. Chest 1992;102(suppl):364-71.
3. Disler LJ, Rosendorff A. Pulmonary hemorrhage following intravenous streptokinase for acute myocardial infarction. Int J Cardiol 1990;29:387-90.
4. Le SP, Chatterjee K, Wolfe CL. Adult respiratory distress syndrome following thrombolytic therapy with APSAC for acute myocardial infarction Am Heart J 1992;123:1368-9.
5. Kerstein MD, Adinolfi MF. Pulmonary dysfunction associated with streptokinase therapy. Arch Surg 1986;121:852-3.
6. Ingram RH Jr. Adult respiratory distress syndrome. In: Wilson JD, Braunwald E, Isselbacher KJ, et al, eds. Harrison's principles of internal medicine, 12th ed. New York: McGraw-Hill, 1991:1122.
7. Timmis GC, Gangadhavan V, Ramos RG, et al. Hemorrhage and the products of fibrinogen digestion after intracoronary administration of streptokinase. Circulation 1984;69:1146-52.
8. Tillet WS, Edwards LB, Garner RL. Fibrinolytic activity of hemolytic streptococcus: the development of resistance to fibrinolysis following acute hemolytic streptococcus infections [abstr]. J Clin Invest 1932;13:47.
9. George RB. History and physical examination. In: George RB, Light RW, Matthay MA, Matthay RA, eds. Chest medicine: essentials of pulmonary and critical care medicine, 2nd ed. Baltimore: Williams & Wilkins, 1990:75-6.
10. Sabharwal AK, Bajaj SP, Ameri A, et al. Tissue factor pathway inhibitor and von Willebrand factor antigen levels in adult respiratory distress syndrome in a primate model of sepsis. Am J Respir Dis Crit Care Med 1995;151:758-67.
11. Sherris JC, Ray CG. An overview of the specific immune response. In: Sherris JC, ed. Medical microbiology. New York: Elsevier, 1990:120-1.
12. McHugh SM, Wilson AB, Deighton J, Lachmann PJ, Ewan PW. The profiles of interleukin (IL)-2, 1L-6, and interferon-gamma production by peripheral blood mononuclear cells from house-dust-mite-allergic patients: a role for IL-6 in allergic disease. Allergy 1994;49(9):751-9.
13. Lynch M, Pentecost BL, Littler WA, Stockley RA. Why do patients develop reactions to streptokinase? Clin Exp Immunol 1993;94(2):279-85.
14. Sakai K, Hosoda S, Shimamoto K. Late rupture of left ventricular true aneurysm after acute myocardial infarction. Clin Cardiol 1993;16:573-5.